软组织肉瘤

B7-H3 在肉瘤中的临床与治疗相关性：来自系统综述的分子见解

Clinical and Therapeutic Relevance of B7-H3 in Sarcomas: Molecular Insights from a Systematic Review.

肉瘤是一组异质性间叶源性恶性肿瘤，以显著的形态学和分子学多样性为特征。

犬软组织肉瘤局部复发的临床和免疫学因素评估

Assessment of Clinical and Immunological Factors of Local Recurrence in Canine Soft Tissue Sarcoma.

阿替利珠单抗在腺泡状软组织肉瘤中取得部分缓解并近乎完全消退广泛肺转移：一例病例报告

A partial response to atezolizumab in alveolar soft part sarcoma with near-complete resolution of extensive pulmonary metastases: a case report.

一线化疗后晚期软组织肉瘤的免疫治疗解救治疗：侧重未分化多形性肉瘤的单中心回顾性分析

Immunotherapy-based salvage therapy in advanced soft tissue sarcoma after first-line chemotherapy: a retrospective single-center analysis with emphasi

基于免疫治疗的方案，尤其是化学免疫治疗，在晚期 STS 中显示出较传统化疗有 PFS 获益的提示，其中 UPS 显示出与疾病控制相关的提示。安全性特征可接受。然而，回顾性设计、历史对照、样本量有限以及总生存期数据不成熟等固有局限性，需要谨慎解读。

儿童软组织肉瘤中的 NK 细胞：一项系统综述

Natural Killer Cells in Paediatric Soft Tissue Sarcomas: A Systematic Review.

软组织肉瘤的免疫治疗——一项持续探索

Immunotherapy in Soft Tissue Sarcomas-An Ongoing Quest.

针对横纹肌肉瘤及其他 FGFR4 表达肿瘤的靶向抗体药物偶联物

Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers.

基于蛋白质组学的方法揭示剪接体组分 SF3B 与 SerpinB9 参与隆突性皮肤纤维肉瘤

Proteomics-based approach reveals the involvement of spliceosomal components SF3B and SerpinB9 in dermatofibrosarcoma protuberans.

SerpinB9 过表达与 DFSP 的纤维肉瘤样特征相关，可能是一个候选预后生物标志物。

优化的 L1CAM-CAR-T 细胞增强对中等抗原密度横纹肌肉瘤模型的活性

Optimized L1CAM-CAR T cells enhance activity against moderate-antigen-density rhabdomyosarcoma models.

恢复软组织肉瘤中 STING 的表达可增强 TIL（肿瘤浸润淋巴细胞）的活化和功能

Restoring STING expression in soft tissue sarcoma increases activation and function of tumor-infiltrating lymphocytes.